Lemonade Inc

Lemonade Inc (LMND) Stock Analysis

$52.960

-0.953 (-1.80%)At close

Loading chart…
High
55.660
Open
53.900
VWAP
53.85
Vol
752.85K
Mkt Cap
1.16B
Low
52.930
Amount
40.54M
EV/EBITDA, TTM
-23.05

Lemonade, Inc. offers renters, homeowners, car, pet, and life insurance. The Company operates through the United States, Europe, including the United Kingdom, providing insurance products to customers through various sales channels. The Company's digital substrate enables it to integrate marketing and onboarding with underwriting and claims processing, collecting, and deploying data. Its technology includes Data Advantage, AI Maya, AI Jim, CX.AI, Forensic Graph, Blender, and Cooper. AI Maya, its onboarding and customer experience bot, uses natural language to guide customers in joining the Company. AI Jim, its claims bot, takes the first notice of loss from its customer without human intervention. It offers pet insurance that covers diagnostics, procedures, medication, accidents or illness. Even its basic pet insurance offering covers blood tests, urinalysis, lab work, and computed tomography scans.

AI analysis of Lemonade Inc (LMND)

hold

Lemonade Inc is currently not a strong buy due to its ongoing losses and mixed analyst ratings. The current price is $52.96, with a forward P/E of 0, indicating uncertainty in future earnings. Although the company anticipates its first profitable quarter in Q4 2026 with an adjusted EBITDA of $8 million, it still projects a net loss of $47 million to $51 million for the full year. The RSI is at 48.83, suggesting it is neither overbought nor oversold, and the stock has experienced a year-to-date decline of 30.28%. The main risk is the ongoing net losses, with the latest reported net income showing a loss of $43.4 million in Q2 2026.

Analyst Ratings (1)

+46.53% upside
Sell
0 Buy
0 Hold
1 Sell
Current: 52.96
Low
40.00
Average
77.60
High
98.00

Morgan Stanley

2026-08-19

Price Target

$56

Equal Weight

Piper Sandler

2026-07-30

Price Target

$51

Neutral

Keefe Bruyette

2026-07-30

Price Target

$48

Market Perform

Piper Sandler

2026-07-15

Price Target

$75

Neutral

Keefe Bruyette

2026-07-08

Price Target

$48

Underperform

Valuation Metrics

The current forward P/E ratio for Lemonade Inc (LMND) is 0.00, compared to its 5-year average forward P/E of -9.58.

Forward P/E

Overvalued
5Y Average P/E
-9.58
Current P/E
0.00
Overvalued
-1.20
Undervalued
-17.96

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-16.53
Current EV/EBITDA
-23.05
Overvalued
6.25
Undervalued
-39.30

Forward P/S

Fair
5Y Average P/S
4.64
Current P/S
2.54
Overvalued
9.32
Undervalued
-0.03

Alphio AI Price Scenarios for LMND

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%LMND

$47.23

Scenario price

B

Base

Base · 50%LMND

$41.83

Scenario price

B

Bear

Bear · 25%LMND

$34.55

Scenario price

Whales holding LMND

S

Softbank Group Capital Limited

+ HoldingLMNDTMUS

-1.33%

3M Return

Events Timeline

2026-08-12 (ET)

14:00:00

Lemonade CFO Expects 8% Yearly Growth in Premium per Customer

2026-07-29 (ET)

17:00:00

Federal Reserve Holds Rates Steady, Major Indices Drop Significantly

12:30:00

Dow Jones Drops 874.35 Points as Oil Prices Surge

12:30:00

Lemonade Shares Drop 22.2% to $48.34

10:30:00

Lemonade Shares Drop 20% to $49.69

News

LMND FAQ — answered by Alphio AI

Lemonade, Inc. offers renters, homeowners, car, pet, and life insurance. The Company operates through the United States, Europe, including the United Kingdom, providing insurance products to customers through various sales channels. The Company's digital substrate enables it to integrate marketing and onboarding with underwriting and claims processing, collecting, and deploying data. Its technology includes Data Advantage, AI Maya, AI Jim, CX.AI, Forensic Graph, Blender, and Cooper. AI Maya, its onboarding and customer experience bot, uses natural language to guide customers in joining the Company. AI Jim, its claims bot, takes the first notice of loss from its customer without human intervention. It offers pet insurance that covers diagnostics, procedures, medication, accidents or illness. Even its basic pet insurance offering covers blood tests, urinalysis, lab work, and computed tomography scans. It operates in the Financials sector (FIRE, MARINE & CASUALTY INSURANCE industry).

Lemonade Inc is currently not a strong buy due to its ongoing losses and mixed analyst ratings. The current price is $52.96, with a forward P/E of 0, indicating uncertainty in future earnings. Although the company anticipates its first profitable quarter in Q4 2026 with an adjusted EBITDA of $8 million, it still projects a net loss of $47 million to $51 million for the full year. The RSI is at 48.83, suggesting it is neither overbought nor oversold, and the stock has experienced a year-to-date decline of 30.28%. The main risk is the ongoing net losses, with the latest reported net income showing a loss of $43.4 million in Q2 2026.

1 analysts cover LMND: 0 rate it Buy, 0 Hold and 1 Sell. The average price target is 77.60.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started